Embecta Corp. (EMBC) vs Turn Therapeutics Inc. (TTRX)

A side-by-side comparison of Embecta Corp. and Turn Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — EMBC vs TTRX

growth of $100 · dividends reinvested · last 1y
EMBC -56.1% (-56.1%/yr)TTRX +76.6% (+76.6%/yr)TTRX compounded faster over this window
50100150200Start $1002026$44$177
EMBC TTRX

EMBC vs TTRX: by the numbers

  • •EMBC is the larger company ($353M vs $347M market cap).
  • •EMBC is profitable (8.59% net margin) while TTRX runs a net loss (0.00%).
  • •EMBC pays a dividend (5.44% yield), while TTRX has no payments in the available dividend history.

Metrics side by side

Valuation

MetricEMBCTTRX
P/E ratio4.02N/A
Forward P/E3.38N/A
P/S ratio0.35N/A
P/B ratioN/A504.79
EV / EBITDA5.38N/A
FCF yield46.63%N/A

Profitability

MetricEMBCTTRX
Gross margin59.89%0.00%
Operating margin24.85%0.00%
Net margin8.59%0.00%
ROEN/A-1229.58%
ROIC17.99%-84.66%

Dividends

MetricEMBCTTRX
Dividend yield5.44%N/A
Payout ratio21.62%N/A

Growth (annualized)

MetricEMBCTTRX
Revenue CAGR (5Y)-0.09%N/A
EPS CAGR (5Y)-26.22%N/A
FCF CAGR (5Y)-16.77%N/A

Frequently asked

Does EMBC or TTRX pay a bigger dividend?
EMBC pays a dividend (5.44% yield), while TTRX has no payments in the available dividend history.
Is EMBC or TTRX more profitable?
EMBC runs the higher net margin — EMBC at 8.59% versus TTRX at 0.00%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.